Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment - Smolen, Josef S; Genovese, Mark C; Takeuchi, Tsutomu; Hyslop, David L; Macias, William L; Rooney, Terence; Chen, Lei; Dickson, Christina L; Riddle Camp, Jennifer; Cardillo, Tracy E; Ishii, Taeko; Winthrop, Kevin L (Journal of rheumatology, 2019)
Keywords: RHEUMATOID ARTHRITIS; BARICITINIB; CLINICAL TRIALS; SAFETY; JANUS KINASE INHIBITOR